We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02138422
Brief Title: A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

First Submitted : May 12, 2014
First Submitted that Met QC Criteria : May 13, 2014
First Posted : May 14, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2021
Last Update Posted : March 1, 2021